SUBJECTS
|
BROWSE
|
CAREER CENTER
|
POPULAR
|
JOIN
|
LOGIN
Business Skills
|
Soft Skills
|
Basic Literacy
|
Certifications
About
|
Help
|
Privacy
|
Terms
Search
Test your basic knowledge |
First Aid Basics
Start Test
Study First
Subjects
:
health-sciences
,
first-aid
Instructions:
Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can
study here
.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.
This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. Adenocarcinoma - papillary carcinoma
Irreversible - plasias
PSA
malignant epithelial tumor
Free radical eliminators
2. PTH- related peptide - TGF- beta - TNF - IL-1
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
causes of increased ESR
ras gene
malignant >1 cell type tumor
3. Heart disease
benign epithelial tumor
Leading cause of death in the US
Primary tumors that met to bone
S-100
4. Neurofibromatosis type 1 17q tumor suppressor
NF1 gene
arsenic target
extrinsic apoptosis
Primary tumors that met to bone
5. Neuroblastoma transcription factor (oncogene)
granulomatous disease
Barrett's esophagus (chronic GI reflux)
L- myc gene
N- myc gene
6. Melanoma - basal cell carcinoma - and especially squamous cell carcinomas of the skin.
N- myc gene
Prostatic acid phosphatase
causes of decreased ESR
Neoplasm associated with xeroderma pigmentosum (albinism)
7. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets
smooth muscle benign tumor
Colon and rectal cancer incidence
Primary tumors that met to brain
Alk - phos
8. Leiomyoma
smooth muscle benign tumor
Resolution of inflammation
lung cancer incidence/mortality
malignant mesenchyme tumor (general)
9. Papillary (thyroid) - Serous (ovary) - Meningioma - Mesothelioma
c - kit gene
Irreversible - plasias
vinyl chloride target
Where you see Psammoma bodies
10. Neutrophils (eos in the gut) - plus other granular leukocytes and antibodies.
cigarette smoke target
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
Where you see Psammoma bodies
Acute inflammatory mediators
11. Prostate (blastic) - thyroid - testes - breast (lytic and blastic) - lung (lytic) - kidney (breast and prostate are most common)
L- myc gene
WT1 gene
smooth muscle benign tumor
Primary tumors that met to bone
12. Liver (hepatocellular carcinoma)
Neoplasm associated with xeroderma pigmentosum (albinism)
aflatoxin target
smooth muscle malignant tumor
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
13. Osteosarcoma
bone malignant tumor
bcl -2 gene
Colon and rectal cancer incidence
acanthosis nigricans (hyperpig and epidermal thickening)
14. ADH
primary amyloidosis
WT1 gene
p16 gene
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
15. Liver (centrilobular necrosis - fatty change)
abl gene
CCl4 target
NF1 gene
WT1 gene
16. AL
primary amyloidosis
benign epithelial tumor
Rb gene
Necrosis
17. Mature teratoma in women
skeletal muscle benign tumor
benign >1 cell type tumor
causes of increased ESR
malignant >1 cell type tumor
18. Tumor marker: carcinoembryonic Ag Very nonspecific
fat malignant tumor
CEA
asbestos target
Rb gene
19. Adenoma - papilloma
benign epithelial tumor
BRAC2 gene
skeletal muscle benign tumor
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
20. Colon carcinoma GTPase (oncogene)
ras gene
c - myc gene
APC gene
c - kit gene
21. Tumor marker: mets to bone - obstructive biliary disease - Paget's
Leukocyte extravasation: rolling
erb - B2 gene
Alk - phos
DPC gene
22. Colorectal cancer (assoc with FAP) 5q tumor suppressor
Bombesin
APC gene
Free radical eliminators
iron poisoning
23. Breast - ovarian and gastric carcinomas tyrosine kinase (oncogene)
erb - B2 gene
Leading cause of death in the US
Alk - phos
NF2 gene
24. Ligand - receptor interactions. Release of perforin and granzyme B.
CA-19-9
Resolution of inflammation
extrinsic apoptosis
p53 gene
25. CML tyrosine kinase (oncogene)
skeletal muscle benign tumor
ret gene
benign epithelial tumor
abl gene
26. Enzymatic degradation and protein denaturation due to exogenous injury. Inflammatory process where intracellular components extravasate.
Neoplasm associated with xeroderma pigmentosum (albinism)
Second - leading cause of death in the US
Necrosis
Leukocyte extravasation: tight binding
27. ACTH or ACTH- like peptide
blood cell malignant tumors
paraneoplastic effects of thymoma - small cell lung carcinoma
paraneoplastic effects of small cell lung carcinoma
cigarette smoke target
28. Esophagus - stomach
Free radical eliminators
nitrosamines (smoked foods) target
CA-19-9
primary amyloidosis
29. Vascular: ICAM-1 Leukocyte: LFA-1 (integrin)
abl gene
BRCA1 gene
malignant mesenchyme tumor (general)
Leukocyte extravasation: tight binding
30. Burkitt's lymphoma transcription factor (oncogene)
intrinsic apoptosis
c - myc gene
Primary tumors that met to liver
blood cell malignant tumors
31. Tumor marker: Hydatifiform moles - choriocarcinomas - gestational trophoblastic tumors.
beta - hCG
calcitonin
NF2 gene
Alkylating agents target
32. Skin (SqCC) - liver (angiosarcoma)
bone malignant tumor
benign >1 cell type tumor
arsenic target
smooth muscle benign tumor
33. Pancreatic cancer (Deleted in Pancreatic Cancer) 18q tumor suppressor
malignant >1 cell type tumor
prostate cancer incidence/mortality
nitrosamines (smoked foods) target
DPC gene
34. Hyperplasia - metaplasia - dysplasia
Reversible - plasias
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)
bone benign tumor
Free radical eliminators
35. Blood (leukemia)
Leukocyte extravasation: diapedesis
Alkylating agents target
L- myc gene
cirrosis (alcohol - hepB or C)
36. MEN type II and III tyrosine kinase (oncogene)
Necrosis
p53 gene
Primary tumors that met to brain
ret gene
37. Lung tumor transcription factor (oncogene)
Free radical eliminators
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
L- myc gene
Rb gene
38. Macrophages and lymphocytes. Persistant destruction and repair.
paraneoplastic effects of leukemias and lymphomas
Chronic inflammatory mediators
Where you see Psammoma bodies
lung cancer incidence/mortality
39. GIST cytokine receptor (oncogene)
cigarette smoke target
c - kit gene
Free radical cell damage
calcitonin
40. Colon cancer (Deleted in Colon Cancer) 18q tumor suppressor
Reversible - plasias
APC gene
alpha - fetoprotein
DCC gene
41. Membrane lipid peroxidation - protein modification and DNA breakage.
bone benign tumor
DCC gene
Free radical cell damage
prostate cancer incidence/mortality
42. Tumor marker: prostate carcinoma marker.
AIDS
Prostatic acid phosphatase
abl gene
CCl4 target
43. Breast cancer 13q tumor suppressor (DNA repair protein)
BRAC2 gene
c - kit gene
calcitonin
aflatoxin target
44. Restoration of normal structure - granulation tissue (vascularized + fibrosis) - abscess (fibrosis + pus) - fistula or scarring (collagen).
PSA
dysplastic nevus
Necrosis
Resolution of inflammation
45. Hemangioma
fat benign tumor
ulcerative colitis
AIDS
blood vessels benign tumor
46. Tumor marker: pancreatic adenocarcinoma
blood vessels benign tumor
CA-19-9
Alk - phos
cigarette smoke target
47. Bladder (transitional cell carcinoma)
Primary tumors that met to liver
Napthalene (aniline) dyes target
intrinsic apoptosis
CA-19-9
48. Angiosarcoma
intrinsic apoptosis
blood vessels malignant tumor
bone malignant tumor
smooth muscle malignant tumor
49. Melanoma 9p tumor suppressor
paraneoplastic effects of small cell lung carcinoma
c - kit gene
Irreversible - plasias
p16 gene
50. Breast and ovarian cancer 17q tumor suppressor (DNA repair protein)
CCl4 target
BRCA1 gene
erb - B2 gene
arsenic target